메뉴 건너뛰기




Volumn 10, Issue 2, 2002, Pages 361-369

Synthesis and biological activity of new 1,4-benzodioxan-arylpiperazine derivatives. Further validation of a pharmacophore model for α1-adrenoceptor antagonists

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZODIOXANARYLPIPERAZINE DERIVATIVE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; METHYL GROUP; NITROGEN; PIPERAZINE; PIPERAZINE DERIVATIVE; PRAZOSIN; PYRIDAZINONE DERIVATIVE; PYRIDINE; RADIOLIGAND; RAUWOLSCINE; UNCLASSIFIED DRUG;

EID: 0036132213     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(01)00286-3     Document Type: Article
Times cited : (44)

References (36)
  • 9
    • 0006857169 scopus 로고    scopus 로고
    • (b)Strader, C. D.; Sigal, I. S.; Dixon, R. A. Trends Pharmacol. Sci. 1989, (Suppl.), 26.
  • 23
    • 0006784637 scopus 로고    scopus 로고
    • Catalyst 4.6; Molecular Simulation, Inc. (MSI): San Diego, CA 92121, USA.
  • 24
    • 0006864712 scopus 로고    scopus 로고
    • De Marinis, R. M.; Wise, M.; Hieble, J. P.; Ruffolo R. R., Jr. In The Alpha-1 Adrenergic Receptor; Ruffolo, R. R., Jr., Ed.; Humana: Clifton, NJ, USA, 1987; p 211.
  • 34
    • 0006850908 scopus 로고    scopus 로고
    • Catalyst force field and potential energy functions are described in the file REFenergy.doc.html provided by MSI along with the program Catalyst 4.6.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.